Differential effects of chronic imipramine and fluoxetine on basal and amphetamine-induced extracellular dopamine levels in rat nucleus accumbens

European Journal of Pharmacology

Volumn 350, Issue 2-3, 1998, Pages 159-164

  Ichikawa, Junji ^a   Kuroki, Toshihide ^a   Meltzer, Herbert Y ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

(Rat); Amphetamine; Antidepressant; Dopamine; Fluoxetine; Imipramine; Microdialysis; Nucle us accumbens

Indexed keywords

AMPHETAMINE; DOPAMINE; FLUOXETINE; IMIPRAMINE; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DELUSION; DEPRESSION; DOSE RESPONSE; DRUG MECHANISM; HALLUCINATION; LIMBIC CORTEX; LONG TERM CARE; MALE; MANIA; NONHUMAN; NUCLEUS ACCUMBENS; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; SCHIZOIDISM; SCHIZOPHRENIA; SUBCUTANEOUS DRUG ADMINISTRATION;

AMPHETAMINE; ANIMALS; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; ANTIDEPRESSIVE AGENTS, TRICYCLIC; AREA UNDER CURVE; DOPAMINE; DOPAMINE UPTAKE INHIBITORS; EXTRACELLULAR SPACE; FLUOXETINE; IMIPRAMINE; MALE; MICRODIALYSIS; NUCLEUS ACCUMBENS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0032486151     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(98)00247-7     Document Type: Article

References (35)

1. Beasley C.M., Masica D.N., Potvin J.H. Fluoxetine: a review of receptor and functional effects and their clinical implications. Psychopharmacology. 107:1992;1-10.
2. Brown A.S., Gershon S. Dopamine and depression. J. Neural Transm. 91:1993;75-109.
3. Carboni E., Tanda G.L., Frau R., Di Chiara G. Blockade of the noradrenaline carrier increases extracellular dopamine concentrations in the prefrontal cortex: evidence that dopamine is taken up in vivo by noradrenergic terminals. J. Neurochem. 55:1990;1067-1070.
4. Clark R.N., Ashby C.R., Dewey S.L., Ramachandran P.V., Strecker R.E. Effect of acute and chronic fluoxetine on extracellular dopamine levels in the caudate-putamen and nucleus accumbens of rat. Synapse. 23:1996;125-131.
5. Coulter D.M., Pillans P.I. Fluoxetine and extrapyramidal side effects. Am. J. Psychiatry. 152:1995;122-125.
6. B receptors in the frontal cortex of olfactory bulbectomised rats. Eur. J. Pharmacol. 262:1994;143-148.
7. Deutch, A.Y., Bourdelais, A.J., Zahm, D.S., 1993. The nucleus accumbens core and shell: accumbal compartments and their functional attributes. In: Kalivas, P.W., Barnes, C.D. (Eds.), Limbic Motor Circuit and Neuropsychiatry. CRC Press, Boca Raton, FL, pp. 45-88.
8. Dewey S.L., Smith G.S., Logan J., Alexoff D., Ding Y.S., King P., Pappas N., Brodie J.D., Ashby C.R. Serotonergic modulation of striatal dopamine measured with positron emission tomography (PET) and in vivo microdialysis. J. Neurosci. 15:1995;821-829.
9. Duncan G.E., Knapp D.J., Little K.Y., Breese G.R. Neuroanatomical specificity and dose dependence in the time course of imipramine-induced beta adrenergic receptor down-regulation in rat brain. J. Pharmacol. Exp. Ther. 271:1994;1699-1704.
10. Gardier A.M., Lepoul E., Trouvin J.H., Chanut E., Dessalles M.C., Jacquot C. Changes in dopamine metabolism in rat forebrain regions after cessation of long-term fluoxetine treatment: relationship with brain concentrations of fluoxetine and norfluoxetine. Life Sci. 54:1994;51-56.
11. Goff D.C., Midha K.K., Sarid-Segal O., Hubbard J.W., Amico E. A placebo-controlled trial of fluoxetine added to neuroleptic in patients with schizophrenia. Psychopharmacology. 117:1995;417-423.
12. Goodnough D.B., Baker G.B. 5-Hydroxytryptamine2 and β-adrenergic receptor regulation in rat brain following chronic treatment with desipramine and fluoxetine alone and in combination. J. Neurochem. 62:1994;2262-2268.
13. Gresch P.J., Sved A.F., Zigmond M.J., Finlay J.M. Local influence of endogenous norepinephrine on extracellular dopamine in rat medial prefrontal cortex. J. Neurochem. 65:1995;111-116.
14. Henry E.W., Chandler L.P., Rasmussen J.G.C. Assessment of manic reactions during treatment with SSRI sertraline. Does this afford benefit? Clin. Neuropharm. 15((Suppl. 1)):1992;317B.
15. Ichikawa J., Meltzer H.Y. Effect of antidepressants on striatal and accumbens extracellular dopamine levels. Eur. J. Pharmacol. 281:1995;255-261.
16. Jordan S., Kramer G.L., Zukas P.K., Moeller M., Petty F. In vivo biogenic amine efflux in medial prefrontal cortex with imipramine, fluoxetine, and fluvoxamine. Synapse. 18:1994;294-297.
17. Kihara T., Ikeda M. Effects of duloxetine, a new serotonin and norepinephrine uptake inhibitor, on extracellular monamine levels in rat frontal cortex. J. Pharmacol. Exp. Ther. 272:1995;177-183.
18. 2 receptors in the rat brain Eur. J. Pharmacol. 304:1996;49-54.
19. Meltzer H.Y., Young M., Metz J., Fanf V.S., Schyve P.M., Arora R.C. Extrapyramidal side effects and increased serum prolactin following fluoxetine, a new antidepressant. J. Neural Transm. 45:1979;165-175.
20. Meltzer H.Y., Ichikawa J., Chai B.-L. Effect of selective serotonin (5-HT) reuptake inhibitors (SSRI) and tricyclic antidepressants on extracellular dopamine (DA), homovanilic acid (HVA) and 5-hydroxy-indoleacetic acid (5-HIAA) in rat striatum (STR). Soc. Neurosci. Abstr. 19:1993;855.
21. Nomikos G.G., Damsma G., Wenkstern D., Fibiger H.C. Chronic desipramine enhances amphetamine-induced increases in interstitial concentrations of dopamine in the nucleus accumbens. Eur. J. Pharmacol. 195:1991;63-73.
22. 1-adrenergic receptors in rat brain after chronic citalopram and fluoxetine treatments. Psychopharmacology. 115:1994;543-546.
23. Paxinos, G., Watson, C., 1986. The Rat Brain in Stereotaxic Coordinates. Academic Press, New York, NY.
24. Peet M. Induction of mania with selective serotonin re-uptake inhibitors and tricyclic antidepressants. Br. J. Psychiatry. 164:1994;549-550.
25. Peet M., Peters S. Drug-induced mania. Drug Safety. 12:1995;146-153.
26. Perry K.W., Fuller R.W. Effect of fluoxetine on serotonin and dopamine concentration in microdialysis fluid from rat striatum. Life Sci. 50:1992;1683-1690.
27. Plasky P. Antidepressant usage in schizophrenia. Schizophrenia Bull. 17:1991;649-657.
28. Pozzi L., Invernizzi R., Cervo L., Vallenbuona F., Samanin R. Evidence that extracellular concentrations of dopamine are regulated by noradrenergic neurons in the frontal cortex of rats. J. Neurochem. 63:1994;195-200.
29. Preskorn S. Targeted pharmacotherapy in depression management: comparative pharmacokinetics of fluoxetine, paroxetine and sertraline. Int. Clin. Psychopharmacol. 9:1994;13-19. Suppl. 3.
30. Rossetti Z.L., D'Aquila P.S., Hmaidan Y., Gessa G.L., Serra G. Repeated treatment with imipramine potentiates cocaine-induced dopamine release and motor stimulation. Eur. J. Pharmacol. 201:1991;243-245.
31. Siris S.G., van Kammen D.P., Docherty J.P. Use of antidepressant drugs in schizophrenia. Arch. Gen. Psychiatry. 35:1978;1368-1377.
32. Tanda G., Carboni E., Frau R., Di Chiara G. Increase of extracellular dopamine in the prefrontal cortex: a trait of drugs with antidepressant potential? Psychopharmacology. 115:1994;285-288.
33. Tanda G., Frau R., Di Chiara G. Chronic desipramine and fluoxetine differentially affect extracellular dopamine in the rat prefrontal cortex. Psychopharmacology. 127:1996;83-87.
34. Tanda G., Bassareo V., Di Chiara G. Mianserin markedly and selectively increases extracellular dopamine in the prefrontal cortex as compared to the nucleus accumbens of the rat. Psychopharmacology. 123:1996;127-130.
35. Wong D.T., Bymaster F.P., Engleman E.A. Prozac (fluoxetine, Lilly 110140), the first selective serotonin uptake inhibitor and an antidepressant drug: twenty years since its first publication. Life Sci. 57:1995;411-441.